Envestnet Portfolio Solutions’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.3M Buy
32,503
+637
+2% +$306K 0.08% 154
2026
Q1
$15.7M Buy
31,866
+3,728
+13% +$2.02M 0.09% 137
2025
Q4
$16.3M Sell
28,138
-4,292
-13% -$2.43M 0.06% 171
2025
Q3
$15.7M Sell
32,430
-1,904
-6% -$886K 0.06% 166
2025
Q2
$13.9M Buy
34,334
+1,816
+6% +$759K 0.05% 181
2025
Q1
$16.2M Sell
32,518
-8,676
-21% -$4.7M 0.06% 149
2024
Q4
$21.4M Sell
41,194
-3,296
-7% -$1.81M 0.07% 129
2024
Q3
$27.5M Buy
44,490
+470
+1% +$278K 0.09% 109
2024
Q2
$24.3M Sell
44,020
-1,431
-3% -$820K 0.08% 118
2024
Q1
$26.4M Buy
45,451
+10,547
+30% +$5.92M 0.1% 106
2023
Q4
$18.5M Sell
34,904
-1,531
-4% -$741K 0.08% 125
2023
Q3
$18.4M Buy
+36,435
New +$19.4M 0.09% 112

Other funds holding TMO

Envestnet Portfolio Solutions's TMO Position: Q2 2026 in Review

Envestnet Portfolio Solutions increased its Thermo Fisher Scientific (TMO) stake by 2% in Q2 2026, buying an estimated $306K and bringing the position to 32,503 shares worth $16.3M. The position accounts for 0.08% of the portfolio, ranked #154.

Envestnet Portfolio Solutions first reported a position in TMO in Q3 2023 and has held it in 12 quarters since. The position peaked at $27.5M in Q3 2024. 637 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Envestnet Portfolio Solutions held 32,503 shares of Thermo Fisher Scientific worth $16.3M as of Q2 2026.
  • Envestnet Portfolio Solutions bought 637 Thermo Fisher Scientific shares in Q2 2026, an estimated $306K.
  • Thermo Fisher Scientific made up 0.08% of Envestnet Portfolio Solutions's portfolio in Q2 2026, its #154 holding.
  • Envestnet Portfolio Solutions first reported a position in Thermo Fisher Scientific in Q3 2023 and has held it in 12 quarters since.
  • Envestnet Portfolio Solutions's Thermo Fisher Scientific position peaked at $27.5M in Q3 2024.
  • 637 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Envestnet Portfolio Solutions's 13F filing for Q2 2026, filed 20 Jul 2026.